EUVIMEDEUVIMED entdecken
Crossref

Abstract 14730: Device-Problem Spectrum and Temporal Trends in Implantable Cardioverter-Defibrillator-Related Death Reports: A Descriptive Analysis of the FDA MAUDE Database, 2016-2026

Mouaz Oudih, Esteban E Rodriguez Ferreira, Mohammed Haroun, Atef Rafat Saied Awdallah, Yonas Gebrecherkos, Anas Haj Ali, Khalid Hussein, Mohamadanas Oudih

Circulation · 02.11.2026 · 154 (Suppl_1)

DOI: 10.1161/circ.154.suppl_1.14730 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, erschienen am 02.11.2026. Verfasst von Mouaz Oudih und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Implantable cardioverter-defibrillators (ICDs) reduce sudden cardiac death; however, characterization of the device problems reported in association with patient deaths relies on passive surveillance. The spectrum and temporal pattern of these reports across manufacturers and device families have not been systematically described in recent years. We present one decade of analysis of ICD-related deaths.

Methods

We queried the FDA Manufacturer and User Facility Device Experience (MAUDE) database for ICD device-related reports with a death outcome. From 7,065 records, we removed duplicates (n=150) and reports with no identified device problem or indeterminate classification, and restricted the dataset to event years 2016 onward, yielding 2,372 reports. Manufacturer labels were consolidated to parent companies; free-text device-problem codes were mapped to mechanistic families and to product families. Proportions are reported with 95% Wilson score confidence intervals.

Results

Reports involved Medtronic (50.9%; 95% CI 48.8-53.0), Abbott/St. Jude (28.6%; 26.7-30.5), Boston Scientific (15.4%; 14.0-17.0), and Biotronik (3.5%). Sensing problems were most common (33.8%; 31.9-35.8), followed by therapy delivery (28.4%; 26.6-30.3), lead/hardware (15.7%), and pacing/capture (10.6%). The device-problem profile differed markedly by product family: Sprint Quattro reports were predominantly sensing-related (62.4%; 58.5-66.1), whereas Quadra/Unify Assura (59.2%) and Cobalt (62.2%) were dominated by therapy-delivery problems, and Endotak Reliance by lead/hardware (48.7%). Annual report volume was non-monotonic, falling from 264 (2016) to 168 (2019) before rising to 238 (2025).

Conclusions

Sensing and therapy-delivery problems dominate ICD-related death reports, with distinct problem signatures across device families. While these unverified data cannot establish device safety or causation, characterizing reports by mechanism and product family highlights specific signals warranting verified investigation

Zitieren

APA

Oudih, M., Ferreira, E. E. R., Haroun, M., Awdallah, A. R. S., Gebrecherkos, Y., Ali, A. H., Hussein, K., & Oudih, M. (2026). Abstract 14730: Device-Problem Spectrum and Temporal Trends in Implantable Cardioverter-Defibrillator-Related Death Reports: A Descriptive Analysis of the FDA MAUDE Database, 2016-2026. Circulation, 154(Suppl_1). https://doi.org/10.1161/circ.154.suppl_1.14730

Vancouver

Oudih M, Ferreira EER, Haroun M, Awdallah ARS, Gebrecherkos Y, Ali AH, et al. Abstract 14730: Device-Problem Spectrum and Temporal Trends in Implantable Cardioverter-Defibrillator-Related Death Reports: A Descriptive Analysis of the FDA MAUDE Database, 2016-2026. Circulation. 2026;154(Suppl_1). doi:10.1161/circ.154.suppl_1.14730

BibTeX
@article{Oudih2026,
  author = {Oudih, Mouaz and Ferreira, Esteban E Rodriguez and Haroun, Mohammed and Awdallah, Atef Rafat Saied and Gebrecherkos, Yonas and Ali, Anas Haj and Hussein, Khalid and Oudih, Mohamadanas},
  title = {Abstract 14730: Device-Problem Spectrum and Temporal Trends in Implantable Cardioverter-Defibrillator-Related Death Reports: A Descriptive Analysis of the FDA MAUDE Database, 2016-2026},
  journal = {Circulation},
  year = {2026},
  volume = {154},
  number = {Suppl_1},
  doi = {10.1161/circ.154.suppl_1.14730}
}
Kostenlos starten →